Fermelanta is a biotech firm that produces rare plant-based ingredients through microbial fermentation.
Fermelanta has raised $13.6M in total funding. The most recent round was Series A. The last funding was announced in August 2025.
Fermelanta's investors include Plug and Play, Mitsubishi UFJ Capital, Beyond Next Ventures, SMBC Venture Capital, Angel Bridge.
Fermelanta is headquartered in Ishikawa, Japan.
Fermelanta is a biotech firm that produces rare plant-based ingredients through microbial fermentation.
Fermelanta is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fermelanta — Funding & Investors." VCBacked, August 29, 2025, https://www.vcbacked.co/company/fermelanta. Accessed November 12, 2026.
VCBacked. (2025). Fermelanta — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/fermelanta
{{cite web |title=Fermelanta — Funding & Investors |url=https://www.vcbacked.co/company/fermelanta |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Fermelanta? Request a listing update